| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |